Dr. Johung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 York St
New Haven, CT 06510Phone+1 203-200-2100
Education & Training
Yale-New Haven Medical CenterResidency, Radiation Oncology, 2009 - 2013- Yale-New Haven HospitalInternship, 2008 - 2009
Yale School of MedicineClass of 2008
Certifications & Licensure
CT State Medical License 2013 - 2025- American Board of Radiology Radiation Oncology
Clinical Trials
- Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma Start of enrollment: 2019 Sep 19
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsPerioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial.Michael Cecchini, Ronald R Salem, Marie Robert, Suzanne Czerniak, Ondrej Blaha
JAMA Oncology. 2024-08-01 - 6 citationsNCCN Guidelines® Insights: Rectal Cancer, Version 3.2024.Al B Benson, Alan P Venook, Mohamed Adam, George Chang, Yi-Jen Chen
Journal of the National Comprehensive Cancer Network. 2024-08-01 - A single arm phase 2 clinical trial of YIV-906 with neoadjuvant concurrent chemo-radiation therapy in patients with locally advanced rectal cancer.Nipun Verma, Kimberly L Johung, Jeremy Kortmansky, Wajih Zaheer, Jill Lacy
Journal of Gastrointestinal Oncology. 2024-06-30
Press Mentions
Botanical Medicine Reduces Rectal Cancer Treatment Side Effects That Can Sideline SurgeriesAugust 9th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
